Versican Plus BbPI IN nasal drops, lyophilisate and solvent for suspension for dogs
Versican Plus BbPI IN nasal drops, lyophilisate and solvent for suspension for dogs
Authorised
- Bordetella bronchiseptica, strain MSLB 3096, Live
- Canine parainfluenza virus 2, strain CPiV-2-Bio 15, Live
Product identification
Medicine name:
Versican Plus BbPI IN nasal drops, lyophilisate and solvent for suspension for dogs
Versican Plus BbPi IN Neusdruppels, lyofilisaat en oplosmiddel voor suspensie
Versican Plus BbPi IN Lyophilisat et solvant pour suspension nasale en gouttes
Versican Plus BbPi IN Lyophyllisat und Lösungsmittel zur Herstellung von Nasentropfen, Suspension
Active substance:
- Bordetella bronchiseptica, strain MSLB 3096, Live
- Canine parainfluenza virus 2, strain CPiV-2-Bio 15, Live
Target species:
-
Dog
Route of administration:
-
Nasal use
Product details
Active substance and strength:
-
Bordetella bronchiseptica, strain MSLB 3096, Live9.80log10 colony forming unit(s)1.00Dose
-
Canine parainfluenza virus 2, strain CPiV-2-Bio 15, Live5.80log10 tissue culture infective dose 501.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for oral suspension
Withdrawal period by route of administration:
-
Nasal use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- (ID2): 1 Box with (10 Vial (Glass) with 1 Dose and 10 Vial (Glass) with 0.5 millilitre(s)) (10.0 Dose, 5.0 millilitre(s))
- (ID1): 1 Box with (5 Vial (Glass) with 1 Dose and 5 Vial (Glass) with 0.5 millilitre(s)) (5.0 Dose, 2.5 millilitre(s))
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- FAMHP
Authorisation number:
- BE-V557964
Date of authorisation status change:
Reference member state:
-
Germany
Procedure number:
- DE/V/0288/001
Concerned member states:
-
Austria
-
Belgium
-
Croatia
-
Cyprus
-
Czechia
-
Estonia
-
France
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?: